[Federal Register Volume 76, Number 90 (Tuesday, May 10, 2011)]
[Notices]
[Pages 27069-27070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-11402]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c) (4), and 552b(c) (6), 
Title 5 U.S.C., as amended. The grant applications and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board Ad hoc 
Subcommittee on Managing Conflict of Interest: Facilitation of 
Industry Interactions.
    Open: June 27, 2011, 1 p.m. to 5 p.m.
    Agenda: Discussion on Managing Conflict of Interest and the 
Facilitation of Industry Interactions.
    Place: Double Tree by Hilton Hotel Bethesda, The Grand Ball 
Room, 8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Mr. Eric Hale, Executive Secretary, NCAB Ad hoc 
Subcommittee on Managing Conflict of Interest and Facilitation of 
Industry Interactions, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Suite 202, Bethesda, 
MD 20892-8345. (301) 496-1148.

    Name of Committee: National Cancer Advisory Board Subcommittee 
on Clinical Investigations.
    Open: June 27, 2011, 6 p.m. to 7:30 p.m.
    Agenda: Discussion on Clinical Investigations.
    Place: Bethesda Hyatt Regency Hotel, One Metro Center, Bethesda, 
MD 20814.
    Contact Person: Dr. Jeff Abrams, Executive Secretary, NCAB 
Subcommittee on Clinical Investigations, National Cancer Institute, 
National Institutes of Health, 6130 Executive Boulevard, Room 7018, 
Bethesda, MD 20892-8345. (301) 496-6138.

    Name of Committee: National Cancer Advisory Board.
    Open: June 28, 2011, 9 a.m. to 3:30 p.m.
    Agenda: Program reports and presentations; business of the 
Board.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Dr. Paulette S. Gray, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327. 
(301) 496-5147.

    Name of Committee: National Cancer Advisory Board.
    Closed: June 28, 2011, 3:45 p.m. to 5 p.m.
    Agenda: Review of grant applications.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Dr. Paulette S. Gray, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327. 
(301) 496-5147.

    Name of Committee: National Cancer Advisory Board.
    Open: June 29, 2011, 9 a.m. to 12 p.m.
    Agenda: Program reports and presentations; business of the 
Board.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.

    Contact Person: Dr. Paulette S. Gray, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327. 
(301) 496-5147.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/ncab.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction;

[[Page 27070]]

93.393, Cancer Cause and Prevention Research; 93.394, Cancer 
Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 
93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 
93.398, Cancer Research Manpower; 93.399, Cancer Control, National 
Institutes of Health, HHS)

    Dated: May 3, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-11402 Filed 5-9-11; 8:45 am]
BILLING CODE 4140-01-P